title: Muscarinic receptors controlling the carbachol-activated nonselective cationic current in guinea pig gastric smooth muscle cells.
abstract: Muscarinic receptor subtypes controlling the nonselective cationic current in response to carbachol (ICCh) were studied in circular smooth muscle cells of the guinea pig gastric antrum using putative muscarinic agonists and antagonists. Both oxotremorine-M (an M2-selective agonist) and CCh dose-dependently activated the cationic current with EC50 values of 0.21 +/- 0.01 microm and 0.97 +/- 0.06 microM, respectively. In contrast, pilocarpine and McN-A 343 (an M1-selective and a putative M4 agonist) were weak partial agonists. In response to 10/microM CCh, 4-DAMP, methoctramine and pirenzepine dose-dependently inhibited ICCh and had IC50 values of 1.91 +/- 0.2 nM, 0.46 +/- 0.07 microM and 8.33 +/- 0.4 microM, respectively. 4-DAMP, methoctramine and pirenzepine shifted the concentration-response curves of ICCh to the right without significantly reducing the maximal current. Values of the apparent dissociation constant pA2 obtained from Schild plot analysis were 9.24, 7.72 and 6.62 for 4-DAMP, methoctramine and pirenzepine, respectively. Also, pertussis toxin completely blocked ICCh generation. These results suggest that the M2-subtype plays a crucial role in the activation of the ICCh, and a block of the M3-subtype reduces the sensitivity of the M2-mediated response with no significant reduction of maximum response.
authors.affiliation: Department of Medicine, Sungkyunkwan University School of Medicine, Suwon, Korea.
authors.forename: J C
authors.initials: JC
authors.lastname: Rhee
authors.forename: P L
authors.initials: PL
authors.lastname: Rhee
authors.forename: M K
authors.initials: MK
authors.lastname: Park
authors.forename: I
authors.initials: I
authors.lastname: So
authors.forename: D Y
authors.initials: DY
authors.lastname: Uhm
authors.forename: K W
authors.initials: KW
authors.lastname: Kim
authors.forename: T M
authors.initials: TM
authors.lastname: Kang
mesh_terms: D000818:Animals; D002217:Carbachol / Q000494:pharmacology*; D002412:Cations; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005753:Gastric Mucosa / Q000378:metabolism; D006168:Guinea Pigs; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D018721:Muscarinic Agonists / Q000494:pharmacology*; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D018408:Patch-Clamp Techniques; D011706:Pyloric Antrum / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D011976:Receptors, Muscarinic / Q000145:classification / Q000502:physiology*; D013270:Stomach / Q000187:drug effects / Q000502:physiology*
chemical_list: D002412:Cations; D007473:Ion Channels; D018721:Muscarinic Agonists; D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D002217:Carbachol